|
Synonyms: capromab pendetide | CYT-351 | CYT-356 | Indium In 111 capromab | ProstaScint®
capromab is an approved drug (FDA (1996))
Compound class:
Antibody
Comment: Used as an imaging agent (ProstaScint) by labelling with the radionuclide Indium-111 (using capromab pendetide, where the pendetide is the chelating agent for the radiolabel).
|
| References |
|
1. Kahn D, Austin JC, Maguire RT, Miller SJ, Gerstbrein J, Williams RD. (1999)
A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy. Cancer Biother Radiopharm, 14 (2): 99-111. [PMID:10850293] |
|
2. Manyak MJ. (2008)
Indium-111 capromab pendetide in the management of recurrent prostate cancer. Expert Rev Anticancer Ther, 8 (2): 175-81. [PMID:18279057] |
